BIOCERA-VET BONE SURGERY RTU
Commercial- Indications
- Bone surgery, Arthrodesis
Company intelligence / Profile preview
TheraVet has launched several products for veterinary orthopedic use. Clinical results for the BIOCERA-VET line are described as extremely promising. For example, a pivotal multicentric European study on VISCO-VET in canine osteoarthritis was completed early due to positive outcomes. The company’s products have been recognized by the Veterinary Orthopedic Society for their efficacy and safety as alternatives to autografts.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TheraVet.